Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Operating Leases (2022 - 2025)

Historic Operating Leases for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $3.2 million.

  • Prokidney's Operating Leases fell 3959.42% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 3959.42%. This contributed to the annual value of $2.5 million for FY2024, which is 3155.12% down from last year.
  • Prokidney's Operating Leases amounted to $3.2 million in Q3 2025, which was down 3959.42% from $3.5 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Operating Leases ranged from a high of $5.6 million in Q2 2024 and a low of $1.7 million during Q3 2022
  • For the 4-year period, Prokidney's Operating Leases averaged around $3.2 million, with its median value being $2.5 million (2025).
  • Its Operating Leases has fluctuated over the past 5 years, first soared by 15471.79% in 2024, then plummeted by 4830.21% in 2025.
  • Over the past 4 years, Prokidney's Operating Leases (Quarter) stood at $1.9 million in 2022, then skyrocketed by 89.4% to $3.6 million in 2023, then tumbled by 31.55% to $2.5 million in 2024, then skyrocketed by 31.32% to $3.2 million in 2025.
  • Its Operating Leases was $3.2 million in Q3 2025, compared to $3.5 million in Q2 2025 and $2.5 million in Q1 2025.